5,758 Shares in CME Group Inc. $CME Acquired by Caprock Group LLC

Caprock Group LLC bought a new position in shares of CME Group Inc. (NASDAQ:CME) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 5,758 shares of the financial services provider’s stock, valued at approximately $1,535,000.

Several other large investors have also bought and sold shares of the business. Jessup Wealth Management Inc raised its position in shares of CME Group by 0.5% during the 2nd quarter. Jessup Wealth Management Inc now owns 7,969 shares of the financial services provider’s stock valued at $2,197,000 after acquiring an additional 36 shares during the last quarter. First Horizon Advisors Inc. increased its holdings in CME Group by 0.7% in the second quarter. First Horizon Advisors Inc. now owns 5,269 shares of the financial services provider’s stock valued at $1,453,000 after purchasing an additional 36 shares during the last quarter. MBM Wealth Consultants LLC lifted its stake in CME Group by 2.7% in the second quarter. MBM Wealth Consultants LLC now owns 1,422 shares of the financial services provider’s stock valued at $392,000 after buying an additional 37 shares during the period. Whittier Trust Co. of Nevada Inc. boosted its holdings in CME Group by 0.8% during the second quarter. Whittier Trust Co. of Nevada Inc. now owns 5,021 shares of the financial services provider’s stock worth $1,384,000 after buying an additional 38 shares during the last quarter. Finally, Atlatl Advisers LLC grew its position in shares of CME Group by 1.8% during the 3rd quarter. Atlatl Advisers LLC now owns 2,126 shares of the financial services provider’s stock worth $574,000 after buying an additional 38 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Stock Performance

Shares of CME stock opened at $303.07 on Friday. CME Group Inc. has a 12 month low of $244.43 and a 12 month high of $309.35. The company’s fifty day simple moving average is $279.82 and its 200-day simple moving average is $274.00. The firm has a market cap of $109.29 billion, a PE ratio of 27.16, a P/E/G ratio of 3.30 and a beta of 0.27. The company has a quick ratio of 1.02, a current ratio of 1.03 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, beating the consensus estimate of $2.75 by $0.02. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The company had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter last year, the company earned $2.52 EPS. CME Group’s revenue for the quarter was up 8.1% compared to the same quarter last year. Equities research analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 26th. Stockholders of record on Tuesday, March 10th will be issued a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. The ex-dividend date of this dividend is Tuesday, March 10th. This is a boost from CME Group’s previous quarterly dividend of $1.25. CME Group’s payout ratio is currently 44.80%.

Insider Activity at CME Group

In related news, CEO Terrence A. Duffy sold 25,000 shares of the business’s stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the transaction, the chief executive officer directly owned 65,804 shares in the company, valued at approximately $17,737,468.20. The trade was a 27.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Dennis Suskind sold 748 shares of the stock in a transaction on Friday, February 6th. The shares were sold at an average price of $300.00, for a total transaction of $224,400.00. Following the completion of the sale, the director owned 2,699 shares of the company’s stock, valued at approximately $809,700. This represents a 21.70% decrease in their position. The SEC filing for this sale provides additional information. 0.30% of the stock is owned by company insiders.

Key Headlines Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME raised shareholder payouts — the board declared a Q1 quarterly dividend of $1.30 (up from $1.25) and an annual variable dividend of $6.15 based on 2025 results (total ≈ $2.2B), both payable March 26; that boosts cash return to investors. CME Group Declares Annual Variable Dividend and Q1 2026 Quarterly Dividend
• Positive Sentiment: Analyst price-target lift — Rothschild & Co Redburn raised its CME price target to $333 from $300 (still a “neutral” rating), implying roughly 9.7% upside versus recent levels, which can support buying interest. Rothschild & Co Redburn Adjusts Price Target on CME Group to $333 From $300, Maintains Neutral Rating
• Positive Sentiment: New product rollout and execution — CME reported first trades in new Cardano, Chainlink and Stellar crypto futures and is actively exploring a rare-earths futures contract; these product additions expand fee pools and diversify revenue. CME Group Announces First Trades for New Cardano, Chainlink and Stellar Cryptocurrency Futures CME Weighs Launching First-Ever Rare Earth Futures Contract / Reuters
• Positive Sentiment: Asia expansion — reports say CME plans to list Taiwan and Hong Kong warehouses for aluminium futures in Asia, a move that could deepen regional market presence and increase volumes. Exclusive: CME to list Taiwan, Hong Kong warehouses in Asia aluminium push, sources say
• Neutral Sentiment: CFTC advisory involvement — the CFTC formed an Innovation Advisory Committee that includes a CME executive; this provides regulatory engagement but unclear near-term financial impact. CFTC Forms Innovation Advisory Committee With 35 Crypto and Finance Industry Leaders
• Neutral Sentiment: Board slate announced — CME named director nominees for the annual meeting; routine governance news that is unlikely to move the stock materially. CME Group Inc. Names Slate of Director Nominees
• Neutral Sentiment: Analyst/earnings commentary — recent analyst-question coverage from the Q4 call provides context for growth drivers but contains no new guidance. 5 Must-Read Analyst Questions From CME Group’s Q4 Earnings Call
• Negative Sentiment: Short-interest reporting is inconsistent — filings flagged a “significant increase” in February short interest but published data show zeros/NaN, creating ambiguity; if short interest is actually rising, that could add downward pressure.

Analysts Set New Price Targets

CME has been the topic of a number of analyst reports. TD Cowen increased their price target on shares of CME Group from $305.00 to $328.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of CME Group from $312.00 to $316.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. Argus lowered their price objective on shares of CME Group from $308.00 to $295.00 in a research report on Friday, October 31st. Jefferies Financial Group reduced their target price on CME Group from $304.00 to $302.00 and set a “buy” rating on the stock in a report on Monday, January 12th. Finally, The Goldman Sachs Group boosted their target price on CME Group from $264.00 to $266.00 and gave the company a “sell” rating in a research note on Monday, February 9th. Nine investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, CME Group has an average rating of “Hold” and a consensus target price of $299.53.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.